Chenwei Wu
Chenwei Wu — researcher or builder tracked in the Angestrom contributor network.
Papers · 3
Evaluating and Understanding Model Editing for Medical Vision Language Models
Model editing promises a fast, targeted way to correct post-deployment mistakes in medical vision-language models (VLMs) without costly retraining. However, existing multimodal model editing benchmarks focus on general-purpose tasks and do not reflect realistic clinical domain requirements and variability. To address this, we introduce M3Bench, a clinically grounded benchmark for multimodal model editing that evaluates whether an edit remains reliable, precise, and generalizable under the challenges of image and text variation, modality and protocol shifts, clinical knowledge composition, and
SLAI T-Rex: Full-Parameter Post-training of the DeepSeek-V4 Family on Ascend SuperPOD
Full-parameter post-training of trillion-parameter-scale MoE models introduces substantial system-level challenges for large-scale distributed training, including severe memory pressure, non-overlapped communication overhead, and inefficient kernel execution. While most large-scale LLM training systems are built around GPU-based clusters, this report presents an end-to-end optimization practice on the Ascend NPU SuperPOD. Using the DeepSeek-V4 model family as the target workload, we develop a hierarchical optimization framework spanning model-level parallelism, computation-communication orches
DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening
Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with